NEWS & VIEWS

Global private equity and venture capital news and research

Oncology focus pays off, says Nextech CEO $

25 Jun 2014

alpsFor life sciences venture firms, it is riskier to have a broad focus than targeting a specific segment of the sector, according to Nextechinvest founding partner and CEO Alfred Scheidegger.

Sorry, to get access to this you need to subscribe for free.

In order to view more content, sign-up to our free daily newsletter.

If you would like to read the premium stories, have complete access to our breaking news and Limited Partner magazine you need to become a Premium Subscriber.

Subscribe to AltAssets today

Login to AltAssets


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016

cat